Management of physical health in patients with schizophrenia: practical recommendations

被引：29
作者：
Heald, A. [1 ]
Montejo, A. L. [2 ]
Millar, H. [4 ]
De Hert, M. [5 ]
McCrae, J. [6 ]
Correll, C. U. [3 ]
机构：
[1] Leighton Hosp, Crewe, England
[2] Univ Clin Hosp, Salamanca, Spain
[3] Zucker Hillside Hosp, New York, NY USA
[4] Carseview Ctr, Dundee, Scotland
[5] Catholic Univ, Univ Psychiat Ctr, Kortenberg, Belgium
[6] European Federat Assoc Families People Mental Ill, Louvain, Belgium
来源：
EUROPEAN PSYCHIATRY | 2010年 / 25卷
关键词：
Physical Health; Schizophrenia; Practical Recommendations; Antipsychotic Therapy; Cardiovascular Disease; Multidisciplinary Care; ANTIPSYCHOTIC MEDICATIONS; METABOLIC SYNDROME; WEIGHT-GAIN; DISORDERS; MACROPROLACTIN; ARIPIPRAZOLE; MECHANISMS; ELEVATION; THERAPY; AGENTS;
D O I：
10.1016/S0924-9338(10)71706-5
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Improved physical health care is a pressing need for patients with schizophrenia. It can be achieved by means of a multidisciplinary team led by the psychiatrist. Key priorities should include: selection of antipsychotic therapy with a low risk of weight gain and metabolic adverse effects; routine assessment, recording and longitudinal tracking of key physical health parameters, ideally by electronic spreadsheets; and intervention to control CVD risk following the same principles as for the general population. A few simple tools to assess and record key physical parameters, combined with lifestyle intervention and pharmacological treatment as indicated, could significantly improve physical outcomes. Effective implementation of strategies to optimise physical health parameters in patients with severe enduring mental illness requires engagement and communication between psychiatrists and primary care in most health settings.
引用
收藏
页码：S41 / S45
页数：5
相关论文
共 31 条
[1]  
Allison DB, 1999, AM J PSYCHIAT, V156, P1686
[2]   Sexual Function in Chronic Illness [J].
Basson, Rosemary ;
Rees, Peter ;
Wang, Run ;
Luis Montejo, Angel ;
Incrocci, Luca .
JOURNAL OF SEXUAL MEDICINE, 2010, 7 (01) :374-388
[3]   Clinicians' recognition of the metabolic adverse effects of antipsychotic medications [J].
Buckley, PF ;
Miller, DD ;
Singer, B ;
Arena, J ;
Stirewalt, EM .
SCHIZOPHRENIA RESEARCH, 2005, 79 (2-3) :281-288
[4]   Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study [J].
Casey, DE ;
Carson, WH ;
Saha, AR ;
Liebeskind, A ;
Ali, MW ;
Jody, D ;
Ingenito, GG .
PSYCHOPHARMACOLOGY, 2003, 166 (04) :391-399
[5]  
Citrome Leslie, 2005, J Psychopharmacol, V19, P102, DOI 10.1177/0269881105059505
[6]   From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics [J].
Correll, C. U. .
EUROPEAN PSYCHIATRY, 2010, 25 :S12-S21
[7]   Does antipsychotic polypharmacy increase the risk for metabolic syndrome? [J].
Correll, Christoph U. ;
Frederickson, Anne M. ;
Kane, John M. ;
Manu, Peter .
SCHIZOPHRENIA RESEARCH, 2007, 89 (1-3) :91-100
[8]   Physical health management in psychiatric settings [J].
De Hert, M. ;
van Winkel, R. ;
Silic, A. ;
Van Eyck, D. ;
Peuskens, J. .
EUROPEAN PSYCHIATRY, 2010, 25 :S22-S28
[9]   Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) [J].
De Hert, M. ;
Dekker, J. M. ;
Wood, D. ;
Kahl, K. G. ;
Holt, R. I. G. ;
Moeller, H. -J. .
EUROPEAN PSYCHIATRY, 2009, 24 (06) :412-424
[10]   Comorbid somatic illnesses in patients with severe mental disorders:: Clinical, policy, and research challenges [J].
Fleischhacker, W. Wolfgang ;
Cetkovich-Bakmas, Marcelo ;
De Hert, Marc ;
Hennekens, Charles H. ;
Lambert, Martin ;
Leucht, Stefan ;
Maj, Mario ;
McIntyre, Roger S. ;
Naber, Dieter ;
Newcomer, John W. ;
Olfson, Mark ;
Osby, Urban ;
Sartorius, Norman ;
Lieberman, And. Leffrey A. .
JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (04) :514-519
1234